Biological Therapy and Hematological Parameters in Rheumatoid Arthritis Patients
Aboud, F., A. Z., A., Metwaly, M., El lithy, S., Farouk, A. (2023). Biological Therapy and Hematological Parameters in Rheumatoid Arthritis Patients. EKB Journal Management System, 90(2), 3182-3188. doi: 10.21608/ejhm.2023.290990
Fatma M. Aboud; Abou Elwafa M. A. Z.; Mohamed M. Metwaly; Sally A. El lithy; Al Shymaa M. Farouk. "Biological Therapy and Hematological Parameters in Rheumatoid Arthritis Patients". EKB Journal Management System, 90, 2, 2023, 3182-3188. doi: 10.21608/ejhm.2023.290990
Aboud, F., A. Z., A., Metwaly, M., El lithy, S., Farouk, A. (2023). 'Biological Therapy and Hematological Parameters in Rheumatoid Arthritis Patients', EKB Journal Management System, 90(2), pp. 3182-3188. doi: 10.21608/ejhm.2023.290990
Aboud, F., A. Z., A., Metwaly, M., El lithy, S., Farouk, A. Biological Therapy and Hematological Parameters in Rheumatoid Arthritis Patients. EKB Journal Management System, 2023; 90(2): 3182-3188. doi: 10.21608/ejhm.2023.290990

Biological Therapy and Hematological Parameters in Rheumatoid Arthritis Patients

The Egyptian Journal of Hospital Medicine
Article 182, Volume 90, Issue 2, January 2023, Page 3182-3188  XML PDF (507.72 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2023.290990
View on SCiNiTO View on SCiNiTO
Authors
Fatma M. Aboud; Abou Elwafa M. A. Z.; Mohamed M. Metwaly; Sally A. El lithy; Al Shymaa M. Farouk
Abstract
Background: Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disorder. One of the primary pro-inflammatory cytokines that involved in joint damage is tumor necrosis factor alpha (TNFα). RA is treated using variety of disease modifying anti-rheumatic drugs (DMARDs). The conventional-synthetic disease modifying anti-rheumatic drugs (cs-DMARDs) are corner stone in the treatment of RA patients, however they have limited efficacy in induction of remission.
Objective: This study aims to assess the hematological impact of biological therapy in Rheumatoid arthritis patients in comparison to conventional synthetic disease modifying anti rheumatic drugs.
Patients and methods: On the other hand, the biological therapies are potent and strong, highly targeted therapy that successfully induce remission. This study compares the hematological effects of biological therapy and conventional synthetic disease-modifying anti-rheumatic medications in patients with rheumatoid arthritis.
Results: Our results showed that patients on biological therapy had lower total leucocytic and neutrophils count with higher lymphocyte count. As well as, they showed statistically highly significant lower RDW with statistically significant higher hematocrit value, Hb concentration, RBCs count and MCV. Finally, we found that there was a statistically significant correlation between the duration of biological therapy and the RDW and MPV, and a highly statistically significant correlation with the values of Hb concentration, total platelet count and their related ratios.
Conclusion: Biological therapy had obvious effects on hematological parameters, and these effects were related partially to the potent nature of these group of drugs and partially related to the nature of each therapeutic agent. Additionally, these hematological effects were in strong correlation with the duration of biological use.
 
Keywords
RA; Biological therapy; cs-DMARDs; RBC; Hb; PLT
Statistics
Article View: 237
PDF Download: 477